Discovery of a pyridine-piperazine-based small molecule that enhances the activity of peptidase neurolysin
- 3 February 2026
- journal article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 393 (3) , 103827
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Neurological Disorders and Stroke (R01NS106879)
- Texas Tech University Health Sciences Center
- Oakland University
This publication has 70 references indexed in Scilit:
- Advancing the study of protein-G4 interactions in DNA repair: Insights from biolayer interferometry2024
- Discovery of the Next Generation of Non-peptidomimetic Neurolysin Activators with High Blood-Brain Barrier Permeability: a Pharmacokinetics Study in Healthy and Stroke AnimalsPharmaceutical Research, 2023
- Structure-activity relationship studies of functionalized aromatic peptidomimetics as neurolysin activatorsBioorganic & Medicinal Chemistry Letters, 2022
- In-Vivo and Ex-Vivo Brain Uptake Studies of Peptidomimetic Neurolysin Activators in Healthy and Stroke AnimalsPharmaceutical Research, 2022
- Recent structural insights into the mechanism of ClpP protease regulation by AAA+ chaperones and small moleculesJournal of Biological Chemistry, 2022
- Peptidase neurolysin is an endogenous cerebroprotective mechanism in acute neurodegenerative disordersMedical Hypotheses, 2019
- Neurolysin: From Initial Detection to Latest AdvancesNeurochemical Research, 2018
- Preparation and preliminary characterization of recombinant neurolysin for in vivo studiesJournal of Biotechnology, 2016
- Surface Plasmon Resonance Analysis of Seven-Transmembrane Receptors2015
- Immunocapture-based fluorometric assay for the measurement of neprilysin-specific enzyme activity in brain tissue homogenates and cerebrospinal fluidJournal of Neuroscience Methods, 2007